EU approves Nanosphere's gram-negative blood assay

03/14/2013 | RTT News

Nanosphere has received CE mark approval to market its Gram-Negative Blood Culture, or BC-GN, test in Europe. The device, which runs on the company's automated Verigene System, allows for the rapid diagnosis of bacteria that can trigger bloodstream infections.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC